These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 31550266)
1. Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines. Welch D; Kahen E; Fridley B; Brohl AS; Cubitt CL; Reed DR PLoS One; 2019; 14(9):e0222228. PubMed ID: 31550266 [TBL] [Abstract][Full Text] [Related]
2. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma. Dos Santos MP; de Farias CB; Roesler R; Brunetto AL; Abujamra AL Oncol Rep; 2014 Feb; 31(2):955-68. PubMed ID: 24316794 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response. Pishas KI; Drenberg CD; Taslim C; Theisen ER; Johnson KM; Saund RS; Pop IL; Crompton BD; Lawlor ER; Tirode F; Mora J; Delattre O; Beckerle MC; Callen DF; Sharma S; Lessnick SL Mol Cancer Ther; 2018 Sep; 17(9):1902-1916. PubMed ID: 29997151 [TBL] [Abstract][Full Text] [Related]
4. Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy. Romo-Morales A; Aladowicz E; Blagg J; Gatz SA; Shipley JM Pediatr Blood Cancer; 2019 Sep; 66(9):e27888. PubMed ID: 31207107 [TBL] [Abstract][Full Text] [Related]
5. Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells. Fiskus W; Sharma S; Shah B; Portier BP; Devaraj SG; Liu K; Iyer SP; Bearss D; Bhalla KN Leukemia; 2014 Nov; 28(11):2155-64. PubMed ID: 24699304 [TBL] [Abstract][Full Text] [Related]
6. Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells. Haydn T; Metzger E; Schuele R; Fulda S Cell Death Dis; 2017 Jun; 8(6):e2879. PubMed ID: 28617441 [TBL] [Abstract][Full Text] [Related]
7. Panobinostat-A Potential Treatment for Metastasized Ewing Sarcoma? A Case Report. van Maldegem AM; Bovée JV; Gelderblom H Pediatr Blood Cancer; 2016 Oct; 63(10):1840-3. PubMed ID: 27245095 [TBL] [Abstract][Full Text] [Related]
8. Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG. Anastas JN; Zee BM; Kalin JH; Kim M; Guo R; Alexandrescu S; Blanco MA; Giera S; Gillespie SM; Das J; Wu M; Nocco S; Bonal DM; Nguyen QD; Suva ML; Bernstein BE; Alani R; Golub TR; Cole PA; Filbin MG; Shi Y Cancer Cell; 2019 Nov; 36(5):528-544.e10. PubMed ID: 31631026 [TBL] [Abstract][Full Text] [Related]
9. Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells. Huang Y; Vasilatos SN; Boric L; Shaw PG; Davidson NE Breast Cancer Res Treat; 2012 Feb; 131(3):777-89. PubMed ID: 21452019 [TBL] [Abstract][Full Text] [Related]
10. Soft drug inhibitors for the epigenetic targets lysine-specific demethylase 1 and histone deacetylases. Seitz J; Auth M; Prinz T; Hau M; Tzortzoglou P; Schulz-Fincke J; Schmidtkunz K; Baniahmad AA; Willmann D; Metzger E; Hein L; Preissl S; Schüle R; Jung M Arch Pharm (Weinheim); 2024 Oct; 357(10):e2400450. PubMed ID: 39004853 [TBL] [Abstract][Full Text] [Related]
12. High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma. Wang S; Hwang EE; Guha R; O'Neill AF; Melong N; Veinotte CJ; Conway Saur A; Wuerthele K; Shen M; McKnight C; Alexe G; Lemieux ME; Wang A; Hughes E; Xu X; Boxer MB; Hall MD; Kung A; Berman JN; Davis MI; Stegmaier K; Crompton BD Clin Cancer Res; 2019 Jul; 25(14):4552-4566. PubMed ID: 30979745 [TBL] [Abstract][Full Text] [Related]
13. Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group. Mascarenhas L; Felgenhauer JL; Bond MC; Villaluna D; Femino JD; Laack NN; Ranganathan S; Meyer J; Womer RB; Gorlick R; Krailo MD; Marina N Pediatr Blood Cancer; 2016 Mar; 63(3):493-8. PubMed ID: 26579879 [TBL] [Abstract][Full Text] [Related]
14. Suberoylanilide hydroxamic acid synergistically enhances the antitumor activity of etoposide in Ewing sarcoma cell lines. Unland R; Clemens D; Heinicke U; Potratz JC; Hotfilder M; Fulda S; Wardelmann E; Frühwald MC; Dirksen U Anticancer Drugs; 2015 Sep; 26(8):843-51. PubMed ID: 26053276 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor. Martins AS; Mackintosh C; Martín DH; Campos M; Hernández T; Ordóñez JL; de Alava E Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3532-40. PubMed ID: 16740780 [TBL] [Abstract][Full Text] [Related]
16. Use of class I histone deacetylase inhibitor romidepsin in combination regimens. Petrich A; Nabhan C Leuk Lymphoma; 2016 Aug; 57(8):1755-65. PubMed ID: 27118119 [TBL] [Abstract][Full Text] [Related]
17. LSD1 coordinates with the SIN3A/HDAC complex and maintains sensitivity to chemotherapy in breast cancer. Yang Y; Huang W; Qiu R; Liu R; Zeng Y; Gao J; Zheng Y; Hou Y; Wang S; Yu W; Leng S; Feng D; Wang Y J Mol Cell Biol; 2018 Aug; 10(4):285-301. PubMed ID: 29741645 [TBL] [Abstract][Full Text] [Related]
18. EORTC/GTO adjuvant chemotherapy program for primary Ewing's sarcoma: results at 5 years. Le Mevel BP; Hoerni B; Durant D; Kenesi C; Salle M; Trifaud A; Liegey-Bagari D; Bainvel JV; Rogez JM; Fumoleau P; Mazabraud A; Dumont J; Tomend B; Brossel E; Garetta M; Guerrin D; Jasmin C; Sancho-Garnier H; Gimenez M Recent Results Cancer Res; 1978; 68():52-9. PubMed ID: 752883 [No Abstract] [Full Text] [Related]
19. DNA methylation profiling opens a new phase in the search of targeted therapy against Ewing sarcoma. Rello-Varona S; Tirado OM Pharmacogenomics; 2017 Sep; 18(14):1307-1309. PubMed ID: 28832268 [No Abstract] [Full Text] [Related]
20. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer. Hosseini A; Minucci S Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]